The American Brain Tumour Association (ABTA) is inviting applications for the 2025 Research Collaboration Grant Program, an enviable grant opportunity that aims to speed up breakthroughs in research into brain tumours and treatment.
Two faculty researchers from different institutions will conduct high-impact and collaborative research with this grant. The goal of the program is to promote collaboration in science that crosses disciplines and spurs breakthroughs in the study, diagnosis, and treatment of brain tumours in both children and adults.
Deadline: December 10, 2025
About the ABTA Research Program
Since its beginning, the ABTA Research Program has aided in the advancement of science in the field of brain tumour research by providing funding for innovative ideas, encouraging collaboration, and investing in young and established researchers.
The 2025 Research Collaboration Grant specifically funds high-risk, high-reward research projects that have the potential to change diagnoses as well as improve treatment processes and outcomes for patients suffering from brain tumours.
By promoting collaboration among organisations and encouraging interdisciplinary collaboration, ABTA aims to accelerate the pace of lifesaving breakthroughs in therapeutic techniques.
Grant Objectives
The program aims to support studies that aid in better understanding the brain tumour’s mechanisms and new treatments. The main goals are:
- Promoting the development of innovative collaboration-based research that incorporates translational, clinical, and fundamental science.
- Facilitating multidisciplinary collaborations beyond the traditional research in biology.
- Facilitating the international cooperation between U.S.-based and international researchers.
- Accelerating the transfer of laboratory findings to clinical use.
Priority Research Areas
Proposals should be focused on one or more research areas:
- Biomarkers for risk, burden of disease, or the response to treatment
- Genetics and brain tumourr biology
- Research in the field of clinical medicine and new diagnostic techniques
- Therapeutic and drug delivery approaches
- Genetic epidemiology and aetiologyy
- High-quality imaging technology and accurate diagnostics.
- Innovative therapeutics and treatment strategies
- Risk assessment and studies on patient outcomes
Projects with strong prospects for clinical translation as well as measurable impact on patients will be given priority.
Allowable Costs
- Equipment for research and laboratory equipment
- Data management and costs for data sharing
- The travel associated with project collaboration and dissemination
- Support for personnel directly linked to project objectives
Non-Allowable Costs
- Overhead or indirect expenses
- Visa and tuition fees
- Costs not directly related to research execution
Eligibility Criteria
The requirements listed below to be eligible:
- Candidates must hold permanent faculty positions at reputable research or academic institutions.
- Have an official doctoral certificate (PhD, MD, or equivalent).
- The project should be directed by a reputable principal investigator (PI) as the Lead PI and a Co-Principal Investigator (Co-PI) from two different institutions.
- Ensure that the Lead Institution, which is a non-profit organisation, is located either in the United States or Canada.
- The Co-PI’s establishment can be situated anywhere in the world as long as it’s an non-governmental, non-profit institution.
- Demonstrate a commitment to collaboration across institutions and practices for data sharing.
Encouraged Collaborations
The ABTA encourages the participation of investigators from the following countries:
- Engineering and artificial intelligence, computational biology or data science background.
- Disciplines that do not fall under the traditional biological sciences to provide new perspectives.
Application Requirements
Candidates must submit a commitment to a Notice of Intent (LOI) by December 10, 2025. The LOI serves as the primary step in the selection process. Apply Now
Required Components of the Letter of Intent
- The project title clearly indicates the focus of the study.
- Biosketches for each Lead PI as well as Co-PI.
- Note of Appreciation From the co-PI’s institution. Co-PI’s school.
- Proposal Narrative (up to three pages) – Describing:
- Structure of teams and institutional roles.
- Research goals and hypotheses.
- Methodology and the scientific basis.
- Expected outcomes and possible medical impact.
Each application must be written in English and submitted via the online ABTA Grant Portal.
Additional Notes
- Applicants must adhere to ABTA’s ethical and research policies, which include guidelines for the use of ethically sourced artificial intelligence in preparing proposals.
- Only applications that are complete and submitted on time will be accepted.
Evaluation and Selection Process
Applications will be subject to an exhaustive peer-review procedure that will focus on the research merit as well as collaboration quality and the potential for translation.
Selection Criteria
- Innovative Science: New approaches which test the paradigms of brain tumor ontumourresearch.
- Collaboration Strength: Synergy evident between the Lead Co-PI and PI expertise.
- Possibility: Achievable within the two-year period.
- Implications: Potential to improve the quality of care for patients, diagnostics or treatment outcomes.
- Diversity: Inclusion of multidisciplinary teams and perspectives that are underrepresented.under-represented.
The successful applicants will be notified after review. Complete proposals will be required for a final review.
Reporting and Dissemination
Following the completion of the project, the Principal Investigator’s contributions were under-represented.Investigator,who is the Lead Investigator,Lead,must:
- Presenting findings during this year’s ABTA National Conference.
- Completely submit financial and final reports that summarise the results and data-sharing actions.
This helps ensure transparency and adds to the worldwide brain tumor summarisetumourresearch community.tumourcommunity..
Why It Matters
The ABTA Research Collaboration Grant aids in the fight against brain tumours through the support of research that is innovative and team-based, which surpasses the boundaries of institutions.
For researchers from Africa, Asia, and Europe, along with the Americas This grant is an opportunity to:
- Partnership with top North American institutions.
- Funding is essential to speed up the pace of clinical and translational research.
- Contribute to the global exchange of knowledge and improve patient treatment.
This program is especially beneficial for African and developing nation scientists who work in conjunction with U.S. or Canadian universities to improve their capacity in science and encourage cross-continental innovation.
Conclusion
The ABTA Research Collaboration Grant Program 2025 allows scientists to conduct innovative, interdisciplinary research that could revolutionise the treatment and diagnosis of brain tumours.
Through the funding of high-risk, high-reward projects and encouraging international collaboration This initiative helps in the fight for global health against one of the most difficult medical problems of our times.
For researchers who want to make an impact in the world the world over, this grant will provide funds and collaborations to help advance the field of science and improve medical care.
Disclaimer
FederalGrantsInfo.com publishes this information for educational purposes only. The applicants should go through the full eligibility guidelines and apply directly through the official ABTA portal by December 10, 2025.